| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 27.996 | 33.430 | 34.737 | 42.060 | 52.410 | 61.801 | 86.005 | 85.583 | 102.316 | 116.571 |
| Total Income - EUR | 27.996 | 33.488 | 35.112 | 44.183 | 53.358 | 61.801 | 86.005 | 85.583 | 106.338 | 116.571 |
| Total Expenses - EUR | 22.625 | 29.715 | 33.943 | 40.181 | 51.843 | 44.420 | 50.171 | 56.025 | 75.265 | 71.556 |
| Gross Profit/Loss - EUR | 5.371 | 3.773 | 1.169 | 4.002 | 1.515 | 17.381 | 35.834 | 29.558 | 31.073 | 45.015 |
| Net Profit/Loss - EUR | 3.847 | 3.062 | -9 | 2.821 | 630 | 16.774 | 35.200 | 28.858 | 30.200 | 41.588 |
| Employees | 2 | 2 | 2 | 3 | 2 | 2 | 3 | 2 | 3 | 3 |
Check the financial reports for the company - Eliamed Pro-Life Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.541 | 1.949 | 0 | 0 | 0 | 0 | 35.522 | 26.130 | 16.578 | 7.065 |
| Current Assets | 8.561 | 7.909 | 8.212 | 12.946 | 30.392 | 44.825 | 37.172 | 34.035 | 36.265 | 49.980 |
| Inventories | 158 | 179 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 624 | 2.274 | 2.261 | 4.007 | 6.337 | 8.438 | 8.036 | 32.727 | 27.821 | 41.377 |
| Cash | 7.780 | 5.456 | 5.951 | 8.940 | 24.054 | 36.387 | 29.136 | 1.308 | 8.444 | 8.603 |
| Shareholders Funds | 8.251 | 6.915 | 6.789 | 9.486 | 672 | 17.398 | 35.241 | 28.907 | 30.248 | 41.636 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.851 | 2.943 | 1.423 | 3.461 | 29.720 | 27.427 | 37.453 | 31.258 | 22.595 | 15.409 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Eliamed Pro-Life Srl